Clinical Trials in Prescott Valley, Arizona

Find clinical trials in Prescott Valley, Arizona. Discover local research opportunities and treatment options in your area.

5 Active Trials Found in Prescott Valley

Showing 5 trials on this page

Page 1 of 1

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

NCT ID: NCT04613596

The KRYSTAL-7 trial is studying a new treatment for patients with advanced non-small cell lung cancer (NSCLC) that has a specific mutation called KRAS G12C. The trial has two parts: the Phase 2 par...

Recruiting

Phase: PHASE2 Conditions: Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

NCT ID: NCT05555732

This clinical trial, called TROPION-Lung07, is investigating a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) that has spread to other parts of the body. The s...

Recruiting

Phase: PHASE3 Conditions: Metastatic Non Small Cell Lung Cancer

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

NCT ID: NCT05633654

The ASCENT-05 clinical trial is studying a new treatment approach for patients with triple negative breast cancer (TNBC) who still have cancer remaining after surgery and previous therapy. This tri...

Recruiting

Phase: PHASE3 Conditions: Triple Negative Breast Cancer

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

NCT ID: NCT06129864

This clinical trial is studying a new treatment called volrustomig for patients with a type of cancer called unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC). This trial...

Recruiting

Phase: PHASE3 Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma

MYLUNG Consortium Part 3: Observational Study

NCT ID: NCT05885698

**Summary of the MYLUNG Consortium Part 3 Trial** The MYLUNG Consortium Part 3 trial is an important study that aims to understand how patients with non-small cell lung cancer (NSCLC) can benefit ...

Recruiting

Conditions: Carcinoma, Non-Small-Cell Lung

Search All Trials Browse All Locations